USFDA completes inspection at Ipca Laboratories’ Piparia unit

26 Aug 2019

US Food and Drug Administration (USFDA) has completed the inspection at Ipca Laboratories’ Formulations manufacturing Unit situated at Piparia (Silvassa). The agency has conducted operations from August 19, 2019 to August 23, 2019. At the conclusion of the inspection, the USFDA issued a Form 483 with 3 observations.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Related Ipca Laboratories Ltd. Links:

Ipca Laboratories Share Price

1233.75 -8.90 (-0.72%) Jan 17, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 454.45
Lupin 766.25
Dr. Reddys Lab 3033.65
Piramal Enterprises 1627.05
Cadila Healthcare 269.10
View more..
Sensex vs Ipca Laboratories
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463